BioHealth News
OS Therapies Accepted Into Johnson & Johnson Innovation – JLABS
ROCKVILLE, Md.--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced that it…
Read More
Women In Bio (WIB) Excited to Participate in the 10th Annual BioHealth Capital Region Forum
Women In Bio (WIB) will be well-represented at the 10th Annual BioHealth Capital Region Forum on September 17th and 18th, 2024, at US Pharmacopeia…
Read More
AURP’s BIO Health Caucus Sponsors 10th Annual BioHealth Capital Region Forum
AURP and its BIO Health Caucus have sponsored the 10th Annual BioHealth Capital Region Forum (Sept 17-18) at US Pharmacopeia in Rockville, MD. Serving…
Read More
Bringing the BioHealth Capital Region to South Africa: A Conversation with Global Innovators on BioTalk
In this special episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., hosts a compelling discussion with three groundbreaking guests…
Read More
Final Week to Apply! Deadline August 30th for the 9th Annual Crab Trap Competition
This is your last chance to apply for this year’s Crab Trap Competition, taking place on September 18th, 2024, during BioHealth Capital Region Week…
Read More
AstraZeneca’s Imfinzi approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery
Based on AEGEAN Phase III trial results which showed Imfinzi-based regimen reduced the risk of recurrence, progression or death by 32% vs. neoadjuvant chemotherapy…
Read More
Axios:Venture capitalists move toward “pay to play”
Venture capitalists are inserting a record number of "pay to play" provisions into term sheets, according to new data from law firm Cooley. Why it matters: This…
Read More
Biden-Harris Administration Announces $150 Million from ARPA-H to Deliver Progress on Biden Cancer Moonshot Goals and Improve Health Outcomes
More than two years ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot with the goals of reducing the cancer…
Read More
TEDCO Announces Kim Mozingo’s Promotion to Vice President, Federal Programs
COLUMBIA, Md., (August 13, 2024) — TEDCO, Maryland’s economic engine for technology companies, is pleased to announce the promotion of Kim Mozingo to vice…
Read More
TEDCO’s Maryland Innovation Initiative (MII) Announces Recent Investments
$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md. (August 13, 2024) — TEDCO, Maryland’s economic engine…
Read More
United Therapeutics to Build Medical Transplant Center in Minnesota
Multi-billion-dollar US-based biotech firm United Therapeutics has announced that it has purchased 32 acres (13 hectares) of land in Minnesota, US, for US$4.5 million…
Read More
Linshom Medical Completes Clinical Study Enrollment at The Ohio State University Wexner Medical Center
BALTIMORE, MARYLAND, US, August 12, 2024 /EINPresswire.com/ -- The study, “Advanced Prediction of Respiratory Depression Episodes with the Linshom Continuous Predictive Respiratory Sensor”, completed…
Read More
Innovating Preclinical Models: Mimetas Leads the Way in Organ Design
In a recent article by Genetic Engineering & Biotechnology News, Paul Vulto, PhD, CEO of Mimetas, discusses the growing demand for advanced organ modeling…
Read More
One Month Countdown: BioHealth Capital Region Week is Nearly Here!
We’re just over a month away from the 2024 BioHealth Capital Region Week, which takes place from September 17th, 18th, and 19th at US Pharmacopeia…
Read More
Baltimore’s Neurotech Innovation Achieves Patent Approval and Featured Cover Story in Prominent Industry Journal
(Baltimore, MD) - Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, proudly announces the issuance of…
Read More